Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain:
Chagas cardiomyopathy
Chagas disease
Echocardiography
Strain imaging
Journal
International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
16
03
2022
revised:
27
04
2022
accepted:
17
05
2022
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
2
6
2022
Statut:
epublish
Résumé
Chagas disease is an endemic protozoan disease with high prevalence in Latin America. Of those infected, 20-30% will develop chronic Chagas cardiomyopathy (CCC) however, prediction using existing clinical criteria remains poor. In this study, we investigated the utility of left ventricular (LV) echocardiographic speckle-tracking global longitudinal strain (GLS) for early detection of CCC. 139 asymptomatic Baseline LV GLS in participants with CCC stage A or B was predictive of progression within 1-year and may guide timing of clinical follow-up and promote early detection or treatment.
Sections du résumé
Background
UNASSIGNED
Chagas disease is an endemic protozoan disease with high prevalence in Latin America. Of those infected, 20-30% will develop chronic Chagas cardiomyopathy (CCC) however, prediction using existing clinical criteria remains poor. In this study, we investigated the utility of left ventricular (LV) echocardiographic speckle-tracking global longitudinal strain (GLS) for early detection of CCC.
Methods and results
UNASSIGNED
139 asymptomatic
Conclusion
UNASSIGNED
Baseline LV GLS in participants with CCC stage A or B was predictive of progression within 1-year and may guide timing of clinical follow-up and promote early detection or treatment.
Identifiants
pubmed: 35647262
doi: 10.1016/j.ijcha.2022.101060
pii: S2352-9067(22)00109-9
pmc: PMC9136131
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101060Informations de copyright
© 2022 Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Am J Trop Med Hyg. 1982 Jan;31(1):42-7
pubmed: 6800274
N Engl J Med. 2011 Jun 30;364(26):2527-34
pubmed: 21714649
J Am Soc Echocardiogr. 2016 Jul;29(7):679-88
pubmed: 27086044
Clin Infect Dis. 2009 Sep 1;49(5):e52-4
pubmed: 19640226
J Am Soc Echocardiogr. 2017 May;30(5):493-502
pubmed: 28284461
J Am Coll Cardiol. 2005 Dec 20;46(12):2183-92
pubmed: 16360044
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
J Am Soc Echocardiogr. 2017 Nov;30(11):1081-1090
pubmed: 28797723
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Circulation. 2007 Mar 6;115(9):1124-31
pubmed: 17339570
Circulation. 2018 Sep 18;138(12):e169-e209
pubmed: 30354432
Ann Intern Med. 2006 May 16;144(10):724-34
pubmed: 16702588
J Card Fail. 2011 Dec;17(12):1028-34
pubmed: 22123367
Circulation. 1987 Jun;75(6):1140-5
pubmed: 3552307
Arq Bras Cardiol. 1985 Oct;45(4):249-56
pubmed: 3835868
PLoS One. 2019 Aug 22;14(8):e0221028
pubmed: 31437176
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Circulation. 2007 Mar 6;115(9):1109-23
pubmed: 17339569
Lancet Infect Dis. 2001 Sep;1(2):92-100
pubmed: 11871482
N Engl J Med. 2015 Jul 30;373(5):456-66
pubmed: 26222561
Arq Bras Cardiol. 2011;97(2 Suppl 3):1-48
pubmed: 21952638
Eur Heart J Cardiovasc Imaging. 2017 May 01;18(8):833-840
pubmed: 28637227
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
Clin Cardiol. 2000 Dec;23(12):883-9
pubmed: 11129673
J Electrocardiol. 2012 Jan-Feb;45(1):43-8
pubmed: 21704321
N Engl J Med. 2015 Oct;373(14):1295-306
pubmed: 26323937
PLoS Negl Trop Dis. 2010 May 18;4(5):e688
pubmed: 20502520